About NyquistAI
NyquistAI is a Healthcare company based in Palo Alto (United States) founded in 2020 by Michelle Wu and Qiang Kou. Provider of cloud-based AI solution for the life sciences industry. NyquistAI has raised $6 million across 1 funding round from investors including Lightspeed Venture Partners, Peterson Ventures and GSR Ventures. Its chief executive, as recorded, is Michelle Wu. NyquistAI offers products and services including Nyquist Pharma, Nyquist MedTech, Nyquist IQ, Nyquist Scholar, and Custom Solutions. Its focus areas include HealthTech, Life Sciences Tech, Data Analysis Platforms and Life Sciences. Its legal entity is Nyquist Data, Inc. Its competitors include Komodo Health, Elucidata and Panalgo; 3 of its 3 listed competitors have raised funding.
Company details
NyquistAI was founded in 2020 and is based in Palo Alto, United States. A cloud-based AI platform is provided for the life sciences sector, focusing on clinical and regulatory intelligence. Access to data aggregation, workflow automation, and predictive analytics for medical devices is enabled through this platform, supporting researchers in the industry.
- Headquarters Palo Alto, United States
- Founders Michelle Wu, Qiang Kou
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nyquistai.com
- Social LinkedIn X
- Legal Name Nyquist Data, Inc.
- Total Equity Funding$6M (USD)
in 1 rounds
- Latest Funding Round$6M (USD), Seed
Mar 2022
- InvestorsLightspeed Venture Partners
& 2 more
Products & Services of NyquistAI
NyquistAI offers a comprehensive portfolio of products and services, including Nyquist Pharma, Nyquist MedTech, Nyquist IQ, Nyquist Scholar, and Custom Solutions.
Platform for clinical pipeline and therapy data analysis
Tool for global clinical and regulatory device data
Automates data analysis and insight generation from reports
Streamlines literature reviews and paper recommendations
Integrates AI for organizational efficiency and workflows
Funding Insights of NyquistAI
NyquistAI has successfully raised a total of $6M through 1 strategic funding round. The most recent funding activity was a Seed round of $6 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6M
- Total Rounds 1
- Last Round Seed — $6M
- First Round $6M
(Mar 2022)
- Investors Count 3
All 1 funding rounds of NyquistAI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2022 | $6M | Seed | – | Peterson Ventures, Lightspeed Venture Partners | – |
3 investors in total: 3 institutional.
Investors in NyquistAI
NyquistAI has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Lightspeed Venture Partners, Peterson Ventures and GSR Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed-stage venture capital investments are provided by Peterson Ventures. | petersonventures.com | Salt Lake City, United States | ||
Venture capital investing in innovative companies across global sectors is undertaken by Lightspeed Venture Partners. | 1997 | lsvp.com | Menlo Park, United States | |
Early-stage tech startups are invested in by GSR Ventures. | gsrventuresglobal.com | Beijing, China |
Investor details for NyquistAI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NyquistAI
2 people are tracked at NyquistAI (2 in leadership).
| Name | Role | Group |
|---|---|---|
Michelle Wu | Co-Founder & CEO | Leadership |
Qiang Kou | Co-Founder | Leadership |
Complete people profiles for NyquistAI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of NyquistAI
2 dated milestones of NyquistAI across 2 years, from founding to its latest funding, stage changes and deals.
- Founded NyquistAI is founded.
- Funding First funding round of $6.0M.
Competitors of NyquistAI
NyquistAI has 3 listed competitors in our database, 3 of them funded. They include Komodo Health, Elucidata and Panalgo.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| komodohealth.com | 2014 | New York, United States | $514M | 269 | Data-driven insights are delivered to healthcare via AI platforms. | |
| elucidata.io | 2015 | San Francisco, United States | $22.7M | 136 | Elucidata is focused on AI-powered biomedical data solutions for drug discovery and precision medicine. | |
| panalgo.com | 1996 | Boston, United States | $78M | Provider of healthcare analytics software for clinics |
Detailed competitors of NyquistAI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NyquistAI
The website of NyquistAI (nyquistai.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 2.7% vs previous month
Websites whose visitors overlap most with NyquistAI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
neuageinstitute.com | neuageinstitute.com | 100% | #4,827,364 | – | |
proedcomblog.com | proedcomblog.com | 100% | – | ||
| innoplexus.com | 97% | 1.8K | #8,665,444 | View details | |
| dlrcgroup.com | 82% | #3,223,238 | View details | ||
| regdesk.co | 81% | 18.5K | #1,526,738 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as NyquistAI (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NyquistAI
NyquistAI was founded in 2020 and raised its 1st funding round 2 years after it was founded.
NyquistAI is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Michelle Wu is the CEO of NyquistAI, as recorded in our data. They have also founded this company.
NyquistAI is a funded company, having raised a total of $6M across 1 funding round to date. The company's 1st funding round was a Seed of $6M, raised on Mar 2022.
NyquistAI was founded in 2020 and is based in Palo Alto, United States. A cloud-based AI platform is provided for the life sciences sector, focusing on clinical and regulatory intelligence. Access to data aggregation, workflow automation, and predictive analytics for medical devices is enabled through this platform, supporting researchers in the industry.
NyquistAI's top competitors include Komodo Health, Elucidata and Panalgo.
NyquistAI offers Nyquist Pharma, Nyquist MedTech, Nyquist IQ, Nyquist Scholar, and Custom Solutions.
NyquistAI has 3 investors. Key investors include Lightspeed Venture Partners, Peterson Ventures, and GSR Ventures.
NyquistAI operates through Nyquist Data, Inc..